Skip to main content
Premium Trial:

Request an Annual Quote

Caprion Signs Biomarker ID Deal with Boehringer Ingelheim

NEW YORK, July 12 (GenomeWeb News) - Caprion Pharmaceuticals said today that it has entered into a research collaboration with Boehringer Ingelheim to identify metabolic and inflammatory disease biomarkers using Caprion's CellCarta proteomics discovery platform.

 

Under the terms of the agreement, Caprion will identify pharmacodynamic markers in plasma resulting from the administration of pre-clinical pharmaceutical compounds, Caprion said.

 

Financial details of the agreement were not disclosed.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.